Suzanne N. Voorrips
Groningen, GR 9700RB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Continuously elevated plasma ketone bodies are linked to adverse outcomes in patients with heart failure.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: September 24, 2025
Quantifying skeletal muscle energy metabolism during exercise in heart failure with preserved ejection fraction using in vivo 31P magnetic resonance spectroscopy.
Journal: ESC heart failure
Published: May 26, 2025
Myocardial ketone body oxidation contributes to empagliflozin-induced improvements in cardiac contractility in murine heart failure.
Journal: European journal of heart failure
Published: July 30, 2024
Circulating ketone bodies as signals for cardiovascular disease and mortality.
Journal: European heart journal
Published: March 30, 2023
Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?
Journal: International journal of molecular sciences
Published: June 29, 2022
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial.
Journal: Journal of cardiac failure
Published: May 12, 2022
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure.
Journal: Journal of lipid and atherosclerosis
Published: December 07, 2021
Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?
Journal: European journal of heart failure
Published: June 22, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026